A comparison of the efficacy of endogenous, exogenous, and combined endogenous-exogenous interferon in the treatment of mice infected with encephalomyocarditis virus.
D000704:Analysis of Variance; D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology; D046508:Culture Techniques; D003588:Cytopathogenic Effect, Viral; D003597:Cytosine Nucleotides / Q000494:pharmacology; D004686:Encephalomyocarditis virus; D007274:Injections, Intraperitoneal; D007372:Interferons / Q000097:blood / Q000494:pharmacology* / Q000502:physiology*; D008297:Male; D008722:Methods; D051379:Mice; D009522:Newcastle disease virus; D009705:Nucleosides / Q000494:pharmacology
D000998:Antiviral Agents; D003597:Cytosine Nucleotides; D009705:Nucleosides; D007372:Interferons